Publicaciones (250) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. 8G modifications rewire tumoral microRNAs

    Nature Cell Biology, Vol. 25, Núm. 9, pp. 1243-1244

  2. A Comparison of Methodologies for Pulmonary Veins Segmentation in High Definition Voltage Maps of Patients with Atrial Fibrillation

    Computing in Cardiology

  3. A Human Hereditary Cardiomyopathy Shares a Genetic Substrate With Bicuspid Aortic Valve

    Circulation, Vol. 147, Núm. 1, pp. 47-65

  4. A Multimodal Scaffold for SDF1 Delivery Improves Cardiac Function in a Rat Subacute Myocardial Infarct Model

    ACS Applied Materials and Interfaces, Vol. 15, Núm. 44, pp. 50638-50651

  5. A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors

    Science translational medicine, Vol. 15, Núm. 695, pp. eabp9229

  6. A hybrid physics-based and data-driven framework for cellular biological systems: Application to the morphogenesis of organoids

    iScience, Vol. 26, Núm. 7

  7. A new FGF15/19-mediated gut-to-heart axis controls cardiac hypertrophy

    Journal of Pathology, Vol. 261, Núm. 3, pp. 335-348

  8. A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer

    Frontiers in Immunology, Vol. 14

  9. A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease

    Parkinsonism and Related Disorders, Vol. 110

  10. A simple method to assess clonogenic survival of irradiated cancer cells

    Methods in Cell Biology, Vol. 174, pp. 127-136

  11. AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity

    Biomedicine and Pharmacotherapy, Vol. 169

  12. APLF and long non-coding RNA NIHCOLE promote stable DNA synapsis in non-homologous end joining

    Cell Reports, Vol. 42, Núm. 1

  13. AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability

    Brain, Behavior, and Immunity, Vol. 108, pp. 255-268

  14. Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation

    Blood, Vol. 141, Núm. 9, pp. 1047-1059

  15. Adipose tissue specific CCL18 associates with cardiometabolic diseases in non-obese individuals implicating CD4+ T cells

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  16. Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism

    Gut

  17. Alginate and collagen-based hydrogel: a novel cardiactherapeutic platform for extracellular vesicle delivery

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  18. Alginate sulfate-nanoparticles loaded with hepatocyte growth factor and insulin-like growth factor-1 improve left ventricular repair in a porcine model of myocardial ischemia reperfusion injury

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 184, pp. 83-91

  19. An engineered periosteum for efficient delivery of rhBMP-2 and mesenchymal progenitor cells during bone regeneration

    npj Regenerative Medicine, Vol. 8, Núm. 1

  20. Antifibrogenic and apoptotic effects of Ocoxin in cultured rat hepatic stellate cells

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 4, pp. 881-890